BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 23188576)

  • 21. Prevalence of human papillomavirus in saliva and cervix of sexually active women.
    Adamopoulou M; Vairaktaris E; Nkenke E; Avgoustidis D; Karakitsos P; Sioulas V; Nisyrios T; Yapijakis C
    Gynecol Oncol; 2013 May; 129(2):395-400. PubMed ID: 23428459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z; Austin RM; Guo M; Zhao C
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types.
    Faust H; Jelen MM; Poljak M; Klavs I; Učakar V; Dillner J
    J Clin Virol; 2013 Apr; 56(4):336-41. PubMed ID: 23290386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
    Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania].
    Feticu L; Bocşan IS; Bondor Cl; Boboş C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):567-74. PubMed ID: 23077955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
    Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Smith JS
    Gynecol Oncol; 2012 Apr; 125(1):175-80. PubMed ID: 22233689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
    Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
    Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies.
    Dinc B; Rota S; Onan A; Bozdayi G; Taskiran C; Biri A; Güner H
    Braz J Infect Dis; 2010; 14(1):19-23. PubMed ID: 20428649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection and genotyping of high-risk human papillomavirus in cervical specimens].
    Chacón J; Sanz I; Rubio MD; de la Morena ML; Díaz E; Mateos ML; Baquero F
    Enferm Infecc Microbiol Clin; 2007 May; 25(5):311-6. PubMed ID: 17504684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing.
    Vorsters A; Van Keer S; Biesmans S; Hens A; De Coster I; Goossens H; Ieven M; Van Damme P
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
    Isidean SD; Coutlée F; Franco EL
    Expert Rev Mol Diagn; 2014 Jan; 14(1):5-16. PubMed ID: 24308341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
    Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
    Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
    Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
    J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.